HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
Clinical trial NCT06313203 · RECRUITING
Trial details
- NCT number
- NCT06313203
- Sponsor
- Oslo University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-13
- Primary completion
- 2031-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.